A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong ...

A deep analysis of semaglutide’s phase 3 AD trials shows no cognitive or functional benefit despite biomarker gains, yet ...

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...

Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...

Novo Nordisk A/S left open the door for additional work on its pill version of Ozempic for Alzheimer’s disease after a pair ...

High-sensitivity C-reactive protein (CRP) decreased significantly in the semaglutide group, with estimated treatment ratios ...

In an era with less political and cultural division — and less tech-driven diversion — the stunning advances in medicine seen ...

For years, Los Altos resident Kim Wilford watched Alzheimer’s Disease rob her beloved mother-in-law of her memories, spirit ...

Blood tests for Alzheimer’s disease are rapidly moving into clinics, promising earlier and easier detection of brain changes ...

Alzheimer’s disease accounts for most of the cases of dementia, a condition characterized by progressive or persistent loss ...

Down syndrome is caused by an extra copy of chromosome 21. Because of genes present on this chromosome that are known to ...